Melissa Andel 11/20/20 Melissa Andel 11/20/20

New Model Would Recalibrate Medicare Payment for Top 50 Part B Drugs

Read More

Melissa Andel 11/20/20 Melissa Andel 11/20/20

Trying to Lower List Prices for Drugs, Trump Administration Removes Rebate ‘Safe Harbor’

Read More

Melissa Andel 10/30/20 Melissa Andel 10/30/20

Feds Rely on Transparency Rule to Expose Rx Rebates

Read More

Melissa Andel 10/28/20 Melissa Andel 10/28/20

CMS Proposes Expanded Definition of External Infusion Pump to Support Beneficiary Access to Home Infusion Therapy

Read More

Melissa Andel 10/26/20 Melissa Andel 10/26/20

Me, Waiting for More Details on the Part D Co-Payment Cards

Read More

Melissa Andel 10/16/20 Melissa Andel 10/16/20

Fri-YAY: The Kids are Alright!

Read More

Melissa Andel 10/15/20 Melissa Andel 10/15/20

Democrats Announce Investigation into Trump’s Part D Copay Cards

Read More

Melissa Andel 10/9/20 Melissa Andel 10/9/20

Fri-YAY: Baby Yoda Goes West

Read More

Melissa Andel 10/2/20 Melissa Andel 10/2/20

Fri-YAY: Happy Birthday, President Carter!

Read More

Melissa Andel 9/28/20 Melissa Andel 9/28/20

Facing the Practical Challenges of Importation

Read More

Melissa Andel 9/28/20 Melissa Andel 9/28/20

Proposal Looks to Expand Access to Affordable Insulin and Epinephrine; Impact Unclear

Read More

Melissa Andel 9/25/20 Melissa Andel 9/25/20

Fri-YAY: DC’s Giant Panda Cub

Read More

Melissa Andel 9/25/20 Melissa Andel 9/25/20

Importation: Oh Yeah, This Happened Too

Read More

Melissa Andel 9/25/20 Melissa Andel 9/25/20

Election Hail Mary: $200 Rx Discount Cards for Seniors

Read More

Melissa Andel 9/22/20 Melissa Andel 9/22/20

WaPo Story on Drug Pricing Misses Opportunity to Talk Biosimilars

Last weekend’s story on drug pricing misses an opportunity to look into the unique challenges facing biosimilars.

Read More

Melissa Andel 9/18/20 Melissa Andel 9/18/20

Fri-YAY: A Juan Soto Appreciation Post

Read More

Melissa Andel 9/17/20 Melissa Andel 9/17/20

Drug Pricing Reform and the Biden Administration

Read More

Melissa Andel 9/17/20 Melissa Andel 9/17/20

International Reference Pricing: What About Part D Plan Sponsors?

Read More

Melissa Andel 9/16/20 Melissa Andel 9/16/20

Reference Pricing in Part D: Will Manufacturers Play Ball?

Read More

Melissa Andel 9/15/20 Melissa Andel 9/15/20

Wait…Can He DO That?!

Read More